Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Besylate for Sedation in ICU ERAS Patients
NCT04947345Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of remimazolam, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT04947345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04947345.